Working… Menu
Trial record 1 of 1 for:    Phase I Trial of AVD Plus Lenalidomide (Revlimid)in Elderly Intermediate or Advanced Stage Hodgkin Lymphoma Patients
Previous Study | Return to List | Next Study

Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients (AVD-Rev)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01056679
Recruitment Status : Completed
First Posted : January 26, 2010
Last Update Posted : March 22, 2018
Information provided by (Responsible Party):
Prof. Dr. Andreas Engert, University of Cologne

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2014
Actual Study Completion Date : February 2016